IP Library Granted Patent US 8,299,258
Granted Patent B2
US 8,299,258 · App. 12/612,089 · Granted Oct 30, 2012

Method of making piperidine derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,299,258
App. No.
12/612,089
Granted
Oct 30, 2012
Kind
B2
Abstract

The present invention relates to a process for the preparation of piperidine derivatives including sufentanil, and their pharmaceutically acceptable salts, such as the citrate salt in which a quaternary ammonium (nosylate) salt of an appropriate piperidine is reacted with a corresponding 4-NO 2 sulfonate ester to produce the desired piperidine derivative at a high purity.

Claims (15)

1. A method of making a 4-anilido-piperidine derivative of formula (4) comprising:

reacting a piperidine ammonium salt of formula (2)

with a 4-NO 2 sulfonate ester of formula (3)

where R is selected from —COOMe or —CH 2 OMe, and where R1 is selected from the following formulae (a), (b), (c), or (d):

to produce the 4-anilido-piperidine derivative.

2. The method of claim 1 wherein the 4-NO 2 sulfonate ester of formula (3) is prepared by reacting an alcohol selected from formula (a1), (b1), (c1), or (d1) with 4-nitrobenzenesulfonyl chloride:

3. The method of claim 1 wherein the piperidine ammonium salt of formula (2) is prepared by debenzylating the intermediate of following formula (1), or a salt thereof:

and then reacting the deprotected intermediate with nitrobenzenesulfonic acid.

4. The method of claim 1 for making sufentanil wherein a piperidine ammonium salt of formula (2B)

is reacted with a 4-NO 2 sulfonate ester of formula (3B)

5. The method of claim 4 wherein the 4-NO 2 sulfonate ester of formula (3B) is prepared by reacting 2-(2-thienyl)ethanol with 4-nitrobenzenesulfonyl chloride.

6. The method of claim 4 wherein the wherein the piperidine ammonium salt of formula (2B) is prepared by debenzylating an intermediate of following formula (1B), or a salt thereof:

and then contacting the deprotected intermediate with nitrobenzenesulfonic acid.

7. The method of claim 5 wherein the wherein the piperidine ammonium salt of formula (2B) is prepared by debenzylating an intermediate of following formula (1B) or a salt thereof:

and then reacting the deprotected intermediate with nitrobenzenesulfonic acid.

Assignments (6)
RELEASE OF FIRST LIEN SECURITY INTEREST IN PATENTS Recorded Mar 6, 2025
From: ROYAL BANK OF CANADA
To: CAMBREX CHARLES CITY, INC.; AVISTA PHARMA SOLUTIONS, INC.; SNAPDRAGON CHEMISTRY, INC.
Reel/Frame 070438/0333 →
RELEASE OF SECOND LIEN SECURITY INTEREST IN PATENTS Recorded Dec 7, 2020
From: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
To: AVISTA PHARMA SOLUTIONS, INC.
Reel/Frame 054630/0307 →
SECOND LIEN PATENT SECURITY AGREEMENT Recorded Dec 4, 2019
From: CAMBREX CHARLES CITY, INC.; AVISTA PHARMA SOLUTIONS, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 051196/0080 →
FIRST LIEN PATENT SECURITY AGREEMENT Recorded Dec 4, 2019
From: AVISTA PHARMA SOLUTIONS, INC.; CAMBREX CHARLES CITY, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 051283/0877 →
NOTICE OF RELEASE OF SECURITY INTEREST IN PATENTS Recorded Dec 4, 2019
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: CAMBREX CHARLES CITY, INC.
Reel/Frame 051283/0903 →
SECURITY INTEREST Recorded Jan 3, 2019
From: CAMBREX CHARLES CITY, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 047895/0053 →